Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin

Gastroenterology

Volumn 152, Issue 1, 2017, Pages 105-110.e1

  Chan, Francis K L ^a   Kyaw, Moe ^a   Tanigawa, Tetsuya ^b   Higuchi, Kazuhide ^c   Fujimoto, Kazuma ^d   Cheong, Pui Kuan ^a   Lee, Vivian ^a   Kinoshita, Yoshikazu ^e   Naito, Yuji ^f   Watanabe, Toshio ^b   Ching, Jessica Y L ^a   Lam, Kelvin ^a   Lo, Angeline ^a   Chan, Heyson ^a   Lui, Rashid ^a   Tang, Raymond S Y ^a   Sakata, Yasuhisa ^d   Tse, Yee Kit ^a   Takeuchi, Toshihisa ^c   Handa, Osamu ^f   Nebiki, Hiroko ^g   Wu, Justin C Y ^a   Abe, Takashi ^h   Mishiro, Tsuyoshi ^e   Ng, Siew C ^a   Arakawa, Tetsuo ^b   more..

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d SAGA UNIVERSITY   (Japan)

^e SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^f KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^g OSAKA CITY GENERAL HOSPITAL   (Japan)

^h Takarazuka Municipal Hospital   (Japan)

Author keywords

Acid Suppressive Drugs; Antiplatelet; ASA; Hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; FAMOTIDINE; HEMOGLOBIN; RABEPRAZOLE; ANTITHROMBOCYTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HONG KONG; HUMAN; JAPAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK REDUCTION; TREATMENT DURATION; TREATMENT OUTCOME; ULCER HEALING; UPPER GASTROINTESTINAL BLEEDING; BLOOD; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; RISK FACTOR; SECONDARY PREVENTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASPIRIN; DOUBLE-BLIND METHOD; FAMOTIDINE; FEMALE; HEMOGLOBINS; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PLATELET AGGREGATION INHIBITORS; PROTON PUMP INHIBITORS; RABEPRAZOLE; RECURRENCE; RISK FACTORS; SECONDARY PREVENTION;

EID: 85006324724     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.09.006     Document Type: Article

References (20)

1. 1 Sung, J.J., Kuipers, E.J., El-Serag, H.B., Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 29 (2009), 938–946.
2. 2 Fujinami, H., Kudo, T., Hosokawsa, A., et al. A study of the changes in the cause of peptic ulcer bleeding. World J Gastrointest Endosc 4 (2012), 323–327.
3. 3 Lewis, J.D., Bilker, W.B., Brensinger, C., et al. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol 97 (2002), 2540–2549.
4. 4 Hearnshaw, S.A., Logan, R.F., Lowe, D., et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 60 (2011), 1327–1335.
5. 5 Hernandez-Diaz, S., Garcia Rodriguez, L.A., Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med, 4, 2006, 22.
6. 6 Taha, A.S., Angerson, W.J., Prasad, R., et al. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs. Aliment Pharmacol Ther 28 (2008), 878–885.
7. 7 Chan, F.K., Chung, S.C., Suen, B.Y., et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 344 (2001), 967–973.
8. 8 Chan, F.K., Ching, J.Y., Hung, L.C., et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 352 (2005), 238–244.
9. 9 Emre, Y., Mesut, S., Aylin, Y., et al. Adverse drug reactions due to drug-drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method. Expert Opin Drug Saf 15 (2016), 223–236.
10. 10 Bhatt, D.L., Cryer, B.L., Contant, C.F., et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363 (2010), 1909–1917.
11. 11 Siller-Matula, J.M., Jilma, B., Schror, K., et al. Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb Haemost 8 (2010), 2624–2641.
12. 12 Kwok, C.S., Loke, Y.K., Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther 31 (2010), 810–823.
13. 13 Taha, A.S., McCloskey, C., Prasad, R., et al. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. Lancet 374 (2009), 119–125.
14. 14 Ng, F.H., Wong, S.Y., Lam, K.F., et al. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Gastroenterology 138 (2010), 82–88.
15. 15 Lanas, A., Bajador, E., Serrano, P., et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 343 (2000), 834–839.
16. 16 Scheiman, J.M., Devereaux, P.J., Herlitz, J., et al. Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON). Heart 97 (2011), 797–802.
17. 17 Chan, F.K., Ching, J.Y., Suen, B.Y., et al. Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users. Gastroenterology 144 (2013), 528–535.
18. 18 Yeomans, N., Lanas, A., Labenz, J., et al. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol 103 (2008), 2465–2473.
19. 19 Lai, K.C., Lam, S.K., Chu, K.M., et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 346 (2002), 2033–2038.
20. 20 Abraham, N.S., Hlatky, M.A., Antman, E.M., et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 105 (2010), 2533–2549.